← Back to screener

Elevance Health, Inc. ELV

Rank #439 · NYSE · $91.2B market cap
Audited by Ernst & Young LLP, no going-concern flag in the latest filing.
Score
65.5
P/E
15.2
P/B
2.21
ROE
14.5%
Op. Margin
5.0%
Debt Ratio
183%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★☆
Good

P/E 15.2x, P/B 2.21x. Ranks in the top 29% of the universe.

Profitability ★★★☆☆
Average

ROE 14.5%. Ranks in the top 45% of the universe.

Safety ★★☆☆☆
Average

Debt ratio 183%. Ranks in the top 59% of the universe.

Growth ★★★☆☆
Good

Revenue growth of 9.4% year over year. Ranks in the top 36% of the universe.

Valuation is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2010$61.3B$4.3B$2.5B$23.0B7.1119
2011$64.9B$4.2B$4.7B$21.4B6.4123
2012$58.7B$4.1B$2.9B$24.9B6.9116
2013$61.5B$3.6B$2.7B$23.3B5.9149
2015$71.0B$4.0B$2.5B$23.8B5.6157
2016$73.9B$4.4B$2.6B$24.8B6.0156
2017$79.2B$4.8B$2.6B$24.3B6.0165
2018$84.9B$4.8B$2.5B$23.0B5.7191
2019$90.0B$4.2B$3.8B$25.1B4.6171
2020$92.1B$5.4B$3.8B$26.5B5.9173
2021$104.2B$6.0B$4.8B$33.2B5.8161
2022$121.9B$6.4B$4.6B$36.1B5.2170
2023$138.6B$7.6B$6.2B$36.2B5.5183
2024$156.6B$8.3B$5.9B$39.3B5.3177
2025$171.3B$8.5B$6.0B$41.3B5.0183

← See the full screener